Studies from model systems suggest that matrix metalloproteinases (MMPs) are causally involved in tumor progression while tissue inhibitors of MMPs (TIMPs) prevent this progression. Here, we show that concentrations of TIMP-1 are significantly higher in breast carcinomas than in fibroadenomas. In pr
High-level JAG1 mRNA and protein predict poor outcome in breast cancer
β Scribed by Dickson, Brendan C; Mulligan, Anna Marie; Zhang, Hui; Lockwood, Gina; O'Malley, Frances P; Egan, Sean E; Reedijk, Michael
- Book ID
- 109889579
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 260 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Synuclein Ξ³ (SNCG), previously identified as a breast cancerβspecific gene (BCSG1), is highly expressed in breast carcinomas but not in normal epithelium. SNCG regulates many pathways in growth and progression of breast cancer. To determine if SNCG is a biomarker for clinical prognosis
## Abstract The prognostic significance of __BRCA2__ mRNA levels in tumor tissues was studied in sporadic breast cancer patients. __BRCA2__ mRNA levels were determined by realβtime PCR. Histologic grade III tumors showed significantly (__p__ = 0.001) higher __BRCA2__ mRNA levels (0.828 Β± 0.102 __BR
The association of mRNA expression levels of leptin receptors (long isoform: Lep-R(L) and short isoform: Lep-R(S)) in breast cancer tissue with patient prognosis was studied with special reference to the serum leptin level or the leptin mRNA level in tumor tissue. Lep-R(L), Lep-R(S) and leptin mRNA